Michael Klagsbrun
19Patents
7h-index
15Co-inventors
63Inventor score
Filing activity: Mar 2, 1981 → Apr 6, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6777534B1 | Peptide antagonists of vascular endothelial growth factor | Human Necessities | 62 | Expired |
| US5811393A | Heparin binding mitogen with homology to epidermal growth factor (EGF) | Human Necessities | 24 | Expired |
| US4882275A | Method of purifying endothelial cell growth factors using immobilized heparin | Human Necessities | 22 | Expired |
| US5789182A | System for assaying binding to a heparin-binding growth factor receptor | Physics | 21 | Expired |
| US4440860A | Stimulating cell growth | Chemistry; Metallurgy | 21 | Expired |
| US6635421B1 | Neuropilins and use thereof in methods for diagnosis and prognosis of cancer | Human Necessities | 9 | Expired |
| US7335357B2 | Antagonists of neuropilin receptor function and use thereof | Human Necessities | 7 | Active |
| US5270197A | Cells expressing a substantial number of surface high affinity HBGF receptors but relatively few low affinity HBGF binding sites and system for assaying binding to HBGF receptor | Physics | 7 | Expired |
| US7273612B2 | Soluble inhibitors of vascular endothelial growth factor and use thereof | Human Necessities | 6 | Expired |
| US7736655B2 | Soluble inhibitors of vascular endothelial growth factor and use thereof | Human Necessities | 5 | Active |
| US8529905B2 | Soluble inhibitors of vascular endothelial growth factor and use thereof | Human Necessities | 4 | Active |
| US5235042A | Endothelial cell growth factor | Human Necessities | 3 | Expired |
| US7731959B2 | Antagonists of neuropilin receptor function and use thereof | Human Necessities | 2 | Expired |
| US7414027B2 | Peptide antagonists of vascular endothelial growth factor | Human Necessities | 2 | Expired |
| US8153585B2 | Peptide antagonists of vascular endothelial growth factor and methods of use thereof | Human Necessities | 0 | Active |
| US6235884A | Heparin binding mitogen with homology to epidermal growth factor (EGF) | Chemistry; Metallurgy | 0 | Expired |
| US12397037B2 | Methods and compositions for immunomodulation | Chemistry; Metallurgy | 0 | Active |
| US10456445B2 | Methods and compositions for immunomodulation | Chemistry; Metallurgy | 0 | Active |
| US8889620B2 | Pharmaceutical compositions comprising peptide antagonists of vascular endothelial growth factor | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.